2026 Marketing Pharma Companies 
Drug Discovery World
DECEMBER 6, 2023
It intends to set amended payment percentages for 2024 to 2026 based on an allowed growth rate that has been increased to 2%. This means that companies will pay a rebate on the sales of branded medicines to the NHS of 21.9% in 2024, 24% in 2025 and 26.8%
Drug Discovery World
OCTOBER 4, 2022
There’s no question that cell and gene therapies have emerged as some of the most promising and innovative medicines on the market. . The global lab automation market for drug discovery is expected to grow by a CAGR of 5% between 2021 – 2026, according to a report by Mordor Intelligence. . Cell and gene therapies.
Drug Discovery World
JANUARY 24, 2024
Wigerinck has taken four drugs (Prezista, Olysio, Jyseleca and Rekambys) to market. Once the big pharma companies join the race for a specific disease or target, the window of opportunity to be successful as an independent biotech company is already closed.
Expert insights. Personalized for you.
147 
Let's personalize your content